Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
- PMID: 26724797
- DOI: 10.1093/humrep/dev316
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Abstract
Study question: What is the impact of ovarian response on cumulative live birth rates (LBR) following utilization of all fresh and frozen embryos in women undergoing their first ovarian stimulation cycle, planned to undergo single embryo transfer (SET).
Summary answer: Cumulative LBR significantly increases with the number of oocytes retrieved.
What is known already: Several studies have addressed the issue of the optimal number of oocytes retrieved following controlled ovarian stimulation (COS) for IVF/ICSI and demonstrated that ovarian response is independently related to LBR following IVF/ICSI. The vast majority of studies pertained only to the outcome of the fresh IVF cycle and did not evaluate the cumulative LBR following the transfer of all fresh and frozen-thawed embryos after a single ovarian stimulation, which is the most meaningful outcome for the infertile patient.
Study design, size, duration: This study is a large cohort analysis of retrospective data from January 2009 to December 2013 in a tertiary medical centre, at the Centre for Reproductive Medicine at the University Hospital of Brussels.
Participants/materials, setting, methods: This study included 1099 eligible consecutive women 18-40 years old undergoing their first IVF cycle and planned to undergo SET in their fresh cycle. All patients were treated with a conventional starting gonadotrophin dose of 150-225 IU recombinant FSH (rFSH) in a fixed GnRH antagonist protocol. Vitrification was used as cryopreservation method. To evaluate the impact of oocyte yield on fresh LBR and on cumulative LBR after utilization of all cryopreserved embryos, patients were categorized into four groups according to the number of oocytes retrieved: 1-3 (Group A), 4-9 (Group B), 10-15 (Group C) or >15 oocytes (Group D).
Main results and the role of chance: Regarding LBR in the fresh IVF/ICSI cycles, unadjusted results did not show any significant difference when comparing either high (>15 oocytes) versus normal (10-15 oocytes) (P = 0.65), or normal (10-15) versus suboptimal (4-9 oocytes) responders (P = 0.2). LBR in the fresh cycles were significantly higher (P < 0.05) in high, normal and suboptimal responders when compared with the low ovarian responder group (1-3 oocytes). Moderate-severe ovarian hyperstimulation syndrome occurred in 11 out of 1099 patients (1%). The cumulative LBR significantly increased with the number of oocytes retrieved (χ(2) test for trend P < 0.001). High responders (>15 oocytes) demonstrated a significantly higher LBR not only versus poor (0-3 oocytes) (P < 0.001) and suboptimal (4-9) responders (P < 0.001), but also versus women with normal (10-15) ovarian response (P = 0.014). Finally, although suboptimal responders had a better outcome compared with poor ovarian responders (P = 0.002), this group had a significantly lower cumulative LBR compared with normal ovarian responders (P = 0.02). Multivariate logistic regression analysis showed that the ovarian response category remained an independent predictive factor (P < 0.001) for cumulative LBR.
Limitations, reasons for caution: This is a cohort analysis based on retrospective data collection. Despite our robust methodological approach, the presence of biases related to retrospective design cannot be excluded. High responders may inherently have had a better prognosis. In addition, we cannot provide any guidance for patients undergoing either multiple embryo transfers or treated with higher gonadotrophin doses.
Wider implications of the findings: Women undergoing COS for their first IVF/ICSI cycle and SET should be informed that, although the number of oocytes retrieved does not affect LBR in the fresh cycle, the higher the oocyte yield, the higher the probability to achieve a live birth after utilization of all cryopreserved embryos. Large cohort studies are needed in order to confirm our results of cumulative LBR in different ovarian stimulation settings with higher stimulation doses.
Study funding/competing interests: No external funding was used for this study. No conflicts of interest are declared.
Keywords: cumulative live birth; live birth rate; ovarian response; ovarian stimulation; single embryo transfer.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).Cochrane Database Syst Rev. 2024 Jan 4;1(1):CD012693. doi: 10.1002/14651858.CD012693.pub3. Cochrane Database Syst Rev. 2024. PMID: 38174816 Review.
-
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2024 Jan 4;1:CD012693. doi: 10.1002/14651858.CD012693.pub3. PMID: 29388198 Free PMC article. Updated. Review.
-
Reduced live-birth rates after IVF/ICSI in women with previous unilateral oophorectomy: results of a multicentre cohort study.Hum Reprod. 2018 Feb 1;33(2):238-247. doi: 10.1093/humrep/dex358. Hum Reprod. 2018. PMID: 29211889
-
Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.Hum Reprod. 2017 Mar 1;32(3):556-567. doi: 10.1093/humrep/dew358. Hum Reprod. 2017. PMID: 28130435 Clinical Trial.
-
Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.Hum Reprod. 2013 Dec;28(12):3236-46. doi: 10.1093/humrep/det386. Epub 2013 Oct 27. Hum Reprod. 2013. PMID: 24166594
Cited by
-
A heatmap for expected cumulative live birth rate in preimplantation genetic testing for monogenic disorders and chromosomal structural rearrangements.J Assist Reprod Genet. 2024 May 16. doi: 10.1007/s10815-024-03141-6. Online ahead of print. J Assist Reprod Genet. 2024. PMID: 38753088
-
The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial.J Ovarian Res. 2024 Apr 15;17(1):81. doi: 10.1186/s13048-024-01391-7. J Ovarian Res. 2024. PMID: 38622741 Free PMC article. Clinical Trial.
-
Exploring gonadotropin dosing effects on MII oocyte retrieval in ovarian stimulation.J Assist Reprod Genet. 2024 Jun;41(6):1557-1567. doi: 10.1007/s10815-024-03102-z. Epub 2024 Apr 4. J Assist Reprod Genet. 2024. PMID: 38573535 Free PMC article.
-
Higher Cumulative Live Birth Rate but Also Higher Late Miscarriage Risk in Non-Obese Women with Polycystic Ovary Syndrome Undergoing the First IVF/ICSI Cycle.Int J Womens Health. 2024 Feb 23;16:289-298. doi: 10.2147/IJWH.S445021. eCollection 2024. Int J Womens Health. 2024. PMID: 38415060 Free PMC article.
-
Investigating Ovulation Induction Outcomes in Patients with Decreased Ovarian Reserve Treated with Double Stimulation during The Follicular and Luteal Phases Compared to The Conventional Antagonist Cycle: A Randomized Clinical Trial.Int J Fertil Steril. 2024 Feb 2;18(2):140-145. doi: 10.22074/ijfs.2023.1978181.1405. Int J Fertil Steril. 2024. PMID: 38368517 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials